EE Impact

GlaxoSmithKline

United Kingdom · Pharma & Healthcare

Also known as: GlaxoSmithKline Healthcare

LeaveRussia detail: Continue Operations

Still operating in Russia

GlaxoSmithKline, GSK is a British pharmaceutical company, one of the largest in the world.

Status last verified 03/08/2026Source checked 01/07/2024Company website ↗LeaveRussia profile ↗

Business in Russia

Stopped the advertising company; stopped clinical trials.

Decision trail

Decision date 24/05/2023 · Reference ↗

Will continue to supply essential medicines, vaccines, medical devices, and equipment in Russia. Halted clinical trials, advertising, and promotion. Russian sales proceeds to go to humanitarian aid (no manufacturing and little raw materia/suply chain reliance). Still operating in Russia with increasing sales and profit volumes in 2022 vs 2021. After the start of Russia's war against Ukraine, the volume of product exports to Russia increased.

Local stats (LeaveRussia)

Assets(RF), mln.USD
149
Capital(RF), mln.USD
89
Glob.Revenue, mln.USD
37707
Revenue(RF), mln.USD
332
Staff(RF), 2021
252
Taxes(RF), mln.USD
16

Status history since 2022

  1. 03/08/2026 operating · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.